Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 4/20 | 0.47 |
| ▸ | GRIA3 | P42263 | 4/20 | 0.47 |
| ▸ | GRIA2 | P42262 | 3/20 | 0.47 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.47 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.47 |
| ▸ | GRIK4 | Q16099 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL287393 | 1.00 | SLC7A5 (0.50) | SLC7A5GRIA1GRIA3GRIA2GRIA4 | |
| SCHEMBL287394 | 1.00 | SLC7A5 (0.50) | SLC7A5GRIA1GRIA3GRIA2GRIA4 | |
| SCHEMBL38374 | 0.87 | SLC7A5 (0.50) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| SCHEMBL10608422 | 0.87 | SLC7A5 (0.50) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| SCHEMBL296690 | 0.87 | SLC7A5 (0.50) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| SCHEMBL17340412 | 0.87 | GRIA1 (0.49) | SLC7A5GRIA1GRIA3GRIA2GRIA4 | |
| Hydrochloric Acid SCHEMBL10421601 | 0.85 | SLC7A5 (0.49) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| Bromide SCHEMBL10477401 | 0.85 | SLC7A5 (0.49) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| Bromide SCHEMBL10477399 | 0.85 | SLC7A5 (0.49) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| Hydrochloric Acid SCHEMBL10477430 | 0.85 | SLC7A5 (0.49) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325469-A1 | Inhibitors of atp synthase - cosmetic and therapeutic uses | FORREST MICHAEL DAVID (GB) | 2025-10-23 | — | — | US | disclosed |
| CN-117157049-A | ATP synthase inhibitor-cosmetic and therapeutic use | 迈克尔·大卫·福雷斯特 | 2023-12-01 | — | — | CN | disclosed |
| EP-4281034-A1 | INHIBITORS OF ATP SYNTHASE - COSMETIC AND THERAPEUTIC USES | Forrest, Michael, David (GB) | 2023-11-29 | — | — | EP | disclosed |
| WO-2022157548-A1 | INHIBITORS OF ATP SYNTHASE - COSMETIC AND THERAPEUTIC USES | FORREST MICHAEL DAVID (GB) | 2022-07-28 | — | — | WO | disclosed |
| US-20060155107-A1 | SSTR1-selective analogs | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2006-07-13 | — | — | US | disclosed |
| US-7019109-B2 | Cyclic somatostatin for use in the treatment and prevention of tumor propagation | THE SALK INSTITUTE FOR BILOGICAL STUDIES (US) | 2006-03-28 | — | — | US | disclosed |
| US-20020173618-A1 | SSTR1-selective analogs | SALK INSTITUTE OF BIOLOGICAL STUDIES, THE | 2002-11-21 | — | — | US | disclosed |
| US-5750499-A | ANTITUMOR | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1998-05-12 | — | — | US | disclosed |
| US-4740500-A | OLIGOPEPTIDES, PROTECTED, ON RESIN SUPPORT | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1988-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325469-A1 | Inhibitors of atp synthase - cosmetic and therapeutic uses | ATP5F1A, ATP5F1B, ATP5ME | SLC7A5 470/4885GRIA1 2295/4885GRIA3 3915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.